Teva Pharmaceutical Industries Ltd. (TEVA)

NYSE: TEVA · IEX Real-Time Price · USD
8.66
-0.04 (-0.46%)
At close: Dec 2, 2022 4:00 PM
8.72
+0.06 (0.69%)
Pre-market: Dec 5, 2022 6:16 AM EST
-0.46%
Market Cap 9.80B
Revenue (ttm) 15.14B
Net Income (ttm) -1.29B
Shares Out 1.11B
EPS (ttm) -0.56
PE Ratio n/a
Forward PE 3.40
Dividend n/a
Ex-Dividend Date n/a
Volume 5,351,976
Open 8.63
Previous Close 8.7
Day's Range 8.61 - 8.72
52-Week Range 6.78 - 11.34
Beta 1.27
Analysts Buy
Price Target 0.03 (-99.7%)
Earnings Date Nov 3, 2022

About TEVA

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it f... [Read more]

Industry Pharmaceuticals
Founded 1901
CEO Kaare Schultz
Employees 34,713
Stock Exchange NYSE
Ticker Symbol TEVA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for TEVA stock is "Buy." The 12-month stock price forecast is 0.03, which is a decrease of -99.65% from the latest price.

Price Target
$0.03
(-99.65% downside)
Analyst Consensus: Buy
Stock Forecasts

News

3 Unparalleled Stocks to Buy That Have Never Been This Cheap

These three leading companies are ripe for the picking and may never be this cheap again.

Other symbols: AMZNGOOGGOOGL
1 hour ago - The Motley Fool

Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO

Teva Pharmaceutical (TEVA) appoints Richard Francis as the company's new president and chief executive officer, effective from Jan 1, 2023.

1 week ago - Zacks Investment Research

Teva Finalizes Nationwide Opioid Settlement Terms

TEL AVIV, Israel & PARSIPPANY, N.J.--( BUSINESS WIRE )--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today that the company has finalize...

1 week ago - Business Wire

Generic drugmakers Teva and Sandoz make major push to biosimilars

Generic drug makers Teva Pharmaceutical Industries and Sandoz say they are planning a significant ramp-up in production of biosimilars – copies of high-priced drugs used to treat illnesses such as rheum...

1 week ago - Reuters

TEVA Stock Alert: What to Know About Teva Pharmaceuticals' New CEO

Teva Pharmaceuticals (NYSE: TEVA ) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO. Francis will take over as the president and CEO of Teva Pharmac...

1 week ago - InvestorPlace

Teva names former Sandoz chief Richard Francis as new CEO

Teva Pharmaceutical Industries Ltd. TEVA, +0.93% on Monday said its current CEO Kåre Schultz will retire on Dec. 31.

1 week ago - Market Watch

Teva Announces Appointment of Richard Francis as President and CEO

TEL AVIV, Israel--( BUSINESS WIRE )--Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”) (NYSE and TASE: TEVA), today announced that the Company's Board of Directors has appointed Richard Fran...

1 week ago - Business Wire

Three-Stock Lunch: AMD, HAS & TEVA

Craig Johnson, chief market technician at Piper Sandler, joins 'Power Lunch' to offer his picks for today's three-stock lunch, looking at the technicals of Advanced Micro, Hasbro and Teva Pharmaceuticals.

Other symbols: AMDHAS
2 weeks ago - CNBC Television

Teva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health Platform

PARSIPPANY, N.J.--( BUSINESS WIRE )--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a new collaboration with Rimidi, a leading clini...

2 weeks ago - Business Wire

Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform

PARSIPPANY, N.J.--( BUSINESS WIRE )--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a new collaboration with HealthSnap, a leading f...

2 weeks ago - Business Wire

Eli Lilly ordered to pay $176.5 mln to Teva in U.S. migraine drug patent trial

Eli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three Teva patents, a Boston federal court jury dec...

Other symbols: LLY
3 weeks ago - Reuters

Adding $100 to These 5 Stocks Would Be a Genius Move Right Now

You don't need a large pile of cash to begin building wealth on Wall Street.

Other symbols: AMFGTBIFOKTA
3 weeks ago - The Motley Fool

Why Teva Stock Stumbled Again on Friday

A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments.

1 month ago - The Motley Fool

TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down

TEVA reports dismal Q3 results, missing estimates for both earnings and sales. It slightly lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact.

1 month ago - Zacks Investment Research

Why Teva Stock Sank On Thursday

There were two major developments with the company, both of which involved piles of money.

1 month ago - The Motley Fool

Teva Pharmaceutical to Replace CEO Kare Schultz

Mr. Schultz said he won't renew his contract that expires in November 2023.

1 month ago - WSJ

Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement

The Israeli company will shell out as much as $4.2 billion nationwide as part of a tentative deal.

1 month ago - Forbes

New York Attorney General Letitia James secures $523 million from Teva Pharmaceuticals for role in opioid crisis

The New York Attorney General's office announced it has secured $523 million from Teva Pharmaceuticals and affiliates for its role in the opioid crisis, effectively marking the end of the state's litiga...

1 month ago - CNN Business

Teva to pay $523 mln to New York as it looks to move past opioid lawsuits

Teva Pharmaceutical Industries Ltd will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the U.S. opioid epidemic.

1 month ago - Reuters

Teva Reports Third Quarter 2022 Financial Results

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd.

1 month ago - Business Wire

FDA warns of Adderall shortage after Teva manufacturing delay

Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's warning of an Adderall shortage after Teva experiences a manufacturing delay.

1 month ago - Yahoo Finance

U.S. FDA warns of ADHD drug Adderall shortage on Teva manufacturing delays

The U.S. Food and Drug Administration said on Wednesday there was a shortage of Adderall, a treatment for attention deficit hyperactivity disorder, following intermittent manufacturing delays at Teva Ph...

1 month ago - Reuters